Emicizumab (Anti-F9 / Factor IX)

Ask supplier a question | View on supplier's website

Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2502
Sku #	A2502-1mg*5
Pricing	1mg*5, $7990.00

Feedback